Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamara L Lamprecht

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Investigative Ophthalmology & Visual Science|December 14, 2011
Effect of circadian clock gene mutations on nonvisual photoreception in the mouseLeah Owens, Ethan Buhr, Daniel C Tu, et al.
Genome Research|February 18, 2011
Biome representational in silico karyotypingValliammai Muthappan, Aaron Y Lee, Tamara L Lamprecht, et al.
The Journal of Clinical Investigation|November 24, 2015
PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemiaChristopher B Cole, Angela M Verdoni, Shamika Ketkar, et al.
Cancer Cell|March 25, 2014
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramersDavid A Russler-Germain, David H Spencer, Margaret A Young, et al.
Blood|January 9, 2013
Genomic impact of transient low-dose decitabine treatment on primary AML cellsJeffery M Klco, David H Spencer, Tamara L Lamprecht, et al.
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Cell|February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Nature|December 10, 2014
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaTerrence N Wong, Giridharan Ramsingh, Andrew L Young, et al.
The Journal of Clinical Investigation|March 26, 2011
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progressionLukas D Wartman, David E Larson, Zhifu Xiang, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Investigative Ophthalmology & Visual Science|December 14, 2011
Effect of circadian clock gene mutations on nonvisual photoreception in the mouseLeah Owens, Ethan Buhr, Daniel C Tu, et al.
Genome Research|February 18, 2011
Biome representational in silico karyotypingValliammai Muthappan, Aaron Y Lee, Tamara L Lamprecht, et al.
The Journal of Clinical Investigation|November 24, 2015
PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemiaChristopher B Cole, Angela M Verdoni, Shamika Ketkar, et al.
Cancer Cell|March 25, 2014
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramersDavid A Russler-Germain, David H Spencer, Margaret A Young, et al.
Blood|January 9, 2013
Genomic impact of transient low-dose decitabine treatment on primary AML cellsJeffery M Klco, David H Spencer, Tamara L Lamprecht, et al.
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Cell|February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Nature|December 10, 2014
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaTerrence N Wong, Giridharan Ramsingh, Andrew L Young, et al.
The Journal of Clinical Investigation|March 26, 2011
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progressionLukas D Wartman, David E Larson, Zhifu Xiang, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Pageof 2